CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Novartis AG (ADR) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Novartis AG (ADR)
Lichtstrasse 35
Phone: +41 613241111p:+41 613241111 Basel, 4056  Switzerland Ticker: NVSNVS

Business Summary
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202312/31/2022YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Non-Executive Chairman of the Board JoergReinhardt 8/1/2013 2/1/2010
Chief Executive Officer, Member of the Executive Committee VasantNarasimhan 2/1/2018 2/1/2016
Independent Non-Executive Vice Chairman of the Board Simon E.Moroney 3/4/2022 2/28/2020
12 additional Officers and Directors records available in full report.

Business Names
Business Name
1 A Pharma GmbH
Abadia Retuerta S.A.
Admune Therapeutics
177 additional Business Names available in full report.

General Information
Number of Employees: 103,000 (As of 6/30/2023)
Outstanding Shares: 2,068,263,550 (As of 6/30/2023)
Shareholders: 186,068
Stock Exchange: NYSE
Federal Tax Id: 000004600
Fax Number: +41 613247826
Email Address: kamran.tavangar@group.novartis.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, September 27, 2023